Posts Tagged ‘prostate cancer news’
Monday, August 26th, 2013
ABC News is reporting that thousands of men in Pennsylvania, and possibly the world over, may have received erroneous PSA test results showing higher than actual levels–and possibly leading to unnecessary biopsies. PSA, or prostate specific antigen levels, are a benchmark physicians use to gauge the likelihood of prostate cancer in their patients. According to the report, the makers of the test issued a global recall in June, citing a 20-23% “positive bias”. The specific product recalled is the Immulite PSA test.
Read more posts on prostate cancer news:
Sex After Radical Prostatectomy
Preventing Climacturia (Urine leakage during sex)
Exosomes and Prostate Cancer Diagnosis
Tags: preventing climacturia, preventing urine leakage during sex, prostate cancer, prostate cancer news, PSA tests, PSA tests recalled, sex after radical prostatectomy, urine leakage during sex, urostop
Posted in Climacturia, Prostate Cancer, Prostate Cancer News, Prostate Surgery, Sexual Incontinence, Urology News, UroStop | Comments Off on False positives on thousands of prostate cancer tests
Wednesday, August 7th, 2013
Xofigo, a newly approved treatment for advanced prostate cancer that has spread to the bones, is said to reduce patient pain levels. The drug, which mimics calcium by binding to bone tissue at tumor sites, has been shown to extend patient survival rates by three months. The binding action of Xofigo allows physicians to target the precise location of bone tumors caused by prostate cancer, and minimizes bone damage caused by tumors. It is reported that Xofigo may allow patients to delay chemotherapy and the use of morphine for pain management. A Xofigo treatment can be administered in a few as 15 minutes.
This prostate cancer news is brought to you by UroSciences– makers of the UroStop variable tension penile loop for sexual incontinence and the PDAD Peyronie’s disease assessment device.
Tags: advanced prostate cancer, PDAD, Peyronie's disease, prostate cancer, prostate cancer news, sexual incontinence, urostop, Xofigo
Posted in PDAD, Prostate Cancer, Prostate Cancer Drugs, Prostate Cancer News, Uncategorized, Urology News, UroStop, Xofigo | Comments Off on Xofigo prostate cancer drug reported to reduce pain
Tuesday, July 16th, 2013
It’s likely that you saw last week’s news headlines about a recent study finding that fish oil, specifically Omega-3 fatty acids naturally found in salmon, flaxseed and other foods, is linked to a increase in prostate cancer. As you might imagine, the headlines drew national, even global, media attention, leaving the medical community in a bit of a spin.
This week, the study that made news headlines last week is facing real scrutiny, as its findings go against everything previously known to be true about fish oil actually reducing the likelihood of many cancers. Multiple studies have found fish oil to be beneficial in preventing cancer, including those performed by the University of California San Francisco, and the Harvard School of Public Health.
As with other studies that have raised eyebrows, experts recommend consulting multiple reputable sources for online medical information, rather than making personal health decisions based on a single article or study. Perhaps this is a great example of both the benefits and drawbacks of having millions of pages of online health information at our fingertips. While we have access to on demand health information, we also must be informed consumers of that information.
This post was brought to you via UroSciences, makers of the UroStop device for preventing climacturia (urine leakage during sex), and the P.D.A.D. assessment tool for Peyronie’s disease.
Follow our Twitter feed for more prostate cancer news and updates to this ongoing story.
Tags: P.D.A.D., Peyronie's, preventing climacturia, prostate cancer, prostate cancer news, urine leakage during sex, urostop
Posted in Prostate Cancer, Prostate Cancer News | Comments Off on Prostate cancer and fish oil study under fire
Thursday, July 11th, 2013
According to a recent report by NPR, men are increasingly selecting robotic prostate surgery, even when they are diagnosed with low risk, slow-growing prostate cancer and not likely to benefit from the heavily marketed new procedures. The study, published in JAMA, also reports that robotic prostate surgery is even increasing among older men diagnosed with slow-growing prostate cancer, who are much more likely to die of other causes. According to the report, men older than 65 with low risk prostate cancer have a 20% risk of dying from the cancer and a 60% chance of dying from another cause.
In recent years, many groups have urged physicians and patients to ease up on early prostate cancer screenings, because of the risk of unnecessary treatment, including prostate surgery resulting in incontinence, impotence, and climacturia (sexual incontinence experienced by up to half of men undergoing prostate surgery). A doctor quoted in the NPR report suggests less frequent testing for younger, low risk patients as a way to steer clear of the temptation to go ahead with new treatments.
For more urology and prostate cancer news, we invite you to follow us on Twitter and Facebook.
Tags: climacturia, impotence, incontinence, new prostate cancer treatments, prostate cancer news, robotic prostate surgery, sexual incontinence
Posted in Climacturia, Prostate Cancer, Prostate Cancer News, Prostate Surgery, Radical Prostatectomy, Sexual Incontinence, UroStop | Comments Off on Robotic Prostate Surgery Increasing Even Among Low Risk Patients Likely to Die of Other Causes
Thursday, July 11th, 2013
According to a recent report by NPR, men are increasingly selecting robotic prostate surgery, even when they are diagnosed with low risk, slow-growing prostate cancer and not likely to benefit from the heavily marketed new procedures. The study, published in JAMA, also reports that robotic prostate surgery is even increasing among older men diagnosed with slow-growing prostate cancer, who are much more likely to die of other causes. According to the report, men older than 65 with low risk prostate cancer have a 20% risk of dying from the cancer and a 60% chance of dying from another cause.
In recent years, many groups have urged physicians and patients to ease up on early prostate cancer screenings, because of the risk of unnecessary treatment, including prostate surgery resulting in incontinence, impotence, and climacturia (sexual incontinence experienced by up to half of men undergoing prostate surgery). A doctor quoted in the NPR report suggests less frequent testing for younger, low risk patients as a way to steer clear of the temptation to go ahead with new treatments.
For more urology and prostate cancer news, we invite you to follow us on Twitter and Facebook.
Tags: climacturia, impotence, incontinence, new prostate cancer treatments, prostate cancer news, robotic prostate surgery, sexual incontinence
Posted in Climacturia, Prostate Cancer, Prostate Cancer News, Prostate Surgery, Radical Prostatectomy, Sexual Incontinence, UroStop | Comments Off on Robotic Prostate Surgery Increasing Even Among Low Risk Patients Likely to Die of Other Causes
|
|
|
